automated pharmacophore model module Search Results


receptor ligand pharmacophore generation module  (Accelrys)
86
Accelrys receptor ligand pharmacophore generation module
<t>Receptor-ligand-pharmacophore</t> generation based on the complex structure of the H-PGDS-quinoline-3-carboxamide. (A) The complex structure of H - PGDS -quinoline-3-carboxamide (PDB ID: 6N4E). The H-PGDS is presented in surface (coloured in purple); quinoline-3-carboxamide is shown in spheres (coloured in yellow). (B) The complex structure of H - PGDS -quinoline-3-carboxamide . The H-PGDS is presented in ribbon (coloured in purple); quinoline-3-carboxamide is shown in spheres (coloured in yellow). (C) Generated pharmacophore features and structure of the H - PGDS -quinoline-3-carboxamide . (The interactive residues of H - PGDS are shown as sticks (gray) and labelled. The quinoline-3-carboxamide is presented in balls-and-sticks (pink). (D) Features at a specific distance correspond to the pharmacophore model Phar-A2HR2 . Pharmacophore features are color‐coded as follows: hydrogen-bond acceptor, green; hydrophobic feature, cyan; ring aromatic feature, orange.
Receptor Ligand Pharmacophore Generation Module, supplied by Accelrys, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/automated+pharmacophore+model+module/2020+biovia+discovery+studio/pmc12444937-59-7-15
Average 86 stars, based on 1 article reviews
receptor ligand pharmacophore generation module - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
3d qsar pharmacophore generation module  (Hypogen Inc)
90
Hypogen Inc 3d qsar pharmacophore generation module
<t>Receptor-ligand-pharmacophore</t> generation based on the complex structure of the H-PGDS-quinoline-3-carboxamide. (A) The complex structure of H - PGDS -quinoline-3-carboxamide (PDB ID: 6N4E). The H-PGDS is presented in surface (coloured in purple); quinoline-3-carboxamide is shown in spheres (coloured in yellow). (B) The complex structure of H - PGDS -quinoline-3-carboxamide . The H-PGDS is presented in ribbon (coloured in purple); quinoline-3-carboxamide is shown in spheres (coloured in yellow). (C) Generated pharmacophore features and structure of the H - PGDS -quinoline-3-carboxamide . (The interactive residues of H - PGDS are shown as sticks (gray) and labelled. The quinoline-3-carboxamide is presented in balls-and-sticks (pink). (D) Features at a specific distance correspond to the pharmacophore model Phar-A2HR2 . Pharmacophore features are color‐coded as follows: hydrogen-bond acceptor, green; hydrophobic feature, cyan; ring aromatic feature, orange.
3d Qsar Pharmacophore Generation Module, supplied by Hypogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/automated+pharmacophore+model+module/3d+qsar+pharmacophore+models/pm29702367-79-0-18
Average 90 stars, based on 1 article reviews
3d qsar pharmacophore generation module - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
g-7220  (Genentech inc)
90
Genentech inc g-7220
<t>Receptor-ligand-pharmacophore</t> generation based on the complex structure of the H-PGDS-quinoline-3-carboxamide. (A) The complex structure of H - PGDS -quinoline-3-carboxamide (PDB ID: 6N4E). The H-PGDS is presented in surface (coloured in purple); quinoline-3-carboxamide is shown in spheres (coloured in yellow). (B) The complex structure of H - PGDS -quinoline-3-carboxamide . The H-PGDS is presented in ribbon (coloured in purple); quinoline-3-carboxamide is shown in spheres (coloured in yellow). (C) Generated pharmacophore features and structure of the H - PGDS -quinoline-3-carboxamide . (The interactive residues of H - PGDS are shown as sticks (gray) and labelled. The quinoline-3-carboxamide is presented in balls-and-sticks (pink). (D) Features at a specific distance correspond to the pharmacophore model Phar-A2HR2 . Pharmacophore features are color‐coded as follows: hydrogen-bond acceptor, green; hydrophobic feature, cyan; ring aromatic feature, orange.
G 7220, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/automated+pharmacophore+model+module/g+7220/us07279573-79-32-16
Average 90 stars, based on 1 article reviews
g-7220 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
catalyst software  (Hypogen Inc)
90
Hypogen Inc catalyst software
<t>Receptor-ligand-pharmacophore</t> generation based on the complex structure of the H-PGDS-quinoline-3-carboxamide. (A) The complex structure of H - PGDS -quinoline-3-carboxamide (PDB ID: 6N4E). The H-PGDS is presented in surface (coloured in purple); quinoline-3-carboxamide is shown in spheres (coloured in yellow). (B) The complex structure of H - PGDS -quinoline-3-carboxamide . The H-PGDS is presented in ribbon (coloured in purple); quinoline-3-carboxamide is shown in spheres (coloured in yellow). (C) Generated pharmacophore features and structure of the H - PGDS -quinoline-3-carboxamide . (The interactive residues of H - PGDS are shown as sticks (gray) and labelled. The quinoline-3-carboxamide is presented in balls-and-sticks (pink). (D) Features at a specific distance correspond to the pharmacophore model Phar-A2HR2 . Pharmacophore features are color‐coded as follows: hydrogen-bond acceptor, green; hydrophobic feature, cyan; ring aromatic feature, orange.
Catalyst Software, supplied by Hypogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/automated+pharmacophore+model+module/software+catalyst+hypogen/us07722876-146-0-10
Average 90 stars, based on 1 article reviews
catalyst software - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
quantitative pharmacophore  (Hypogen Inc)
90
Hypogen Inc quantitative pharmacophore
<t>Receptor-ligand-pharmacophore</t> generation based on the complex structure of the H-PGDS-quinoline-3-carboxamide. (A) The complex structure of H - PGDS -quinoline-3-carboxamide (PDB ID: 6N4E). The H-PGDS is presented in surface (coloured in purple); quinoline-3-carboxamide is shown in spheres (coloured in yellow). (B) The complex structure of H - PGDS -quinoline-3-carboxamide . The H-PGDS is presented in ribbon (coloured in purple); quinoline-3-carboxamide is shown in spheres (coloured in yellow). (C) Generated pharmacophore features and structure of the H - PGDS -quinoline-3-carboxamide . (The interactive residues of H - PGDS are shown as sticks (gray) and labelled. The quinoline-3-carboxamide is presented in balls-and-sticks (pink). (D) Features at a specific distance correspond to the pharmacophore model Phar-A2HR2 . Pharmacophore features are color‐coded as follows: hydrogen-bond acceptor, green; hydrophobic feature, cyan; ring aromatic feature, orange.
Quantitative Pharmacophore, supplied by Hypogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/automated+pharmacophore+model+module/quantitative+pharmacophore/pmc03617406-447-9-8
Average 90 stars, based on 1 article reviews
quantitative pharmacophore - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
pharmacophore  (Lundbeck)
86
Lundbeck pharmacophore
<t>Receptor-ligand-pharmacophore</t> generation based on the complex structure of the H-PGDS-quinoline-3-carboxamide. (A) The complex structure of H - PGDS -quinoline-3-carboxamide (PDB ID: 6N4E). The H-PGDS is presented in surface (coloured in purple); quinoline-3-carboxamide is shown in spheres (coloured in yellow). (B) The complex structure of H - PGDS -quinoline-3-carboxamide . The H-PGDS is presented in ribbon (coloured in purple); quinoline-3-carboxamide is shown in spheres (coloured in yellow). (C) Generated pharmacophore features and structure of the H - PGDS -quinoline-3-carboxamide . (The interactive residues of H - PGDS are shown as sticks (gray) and labelled. The quinoline-3-carboxamide is presented in balls-and-sticks (pink). (D) Features at a specific distance correspond to the pharmacophore model Phar-A2HR2 . Pharmacophore features are color‐coded as follows: hydrogen-bond acceptor, green; hydrophobic feature, cyan; ring aromatic feature, orange.
Pharmacophore, supplied by Lundbeck, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/automated+pharmacophore+model+module/pharmacophore/pm17352465__jm070003nsi20070131_070545-0-5-62
Average 86 stars, based on 1 article reviews
pharmacophore - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
hypogen pxr pharmacophores  (Hypogen Inc)
90
Hypogen Inc hypogen pxr pharmacophores
<t>Receptor-ligand-pharmacophore</t> generation based on the complex structure of the H-PGDS-quinoline-3-carboxamide. (A) The complex structure of H - PGDS -quinoline-3-carboxamide (PDB ID: 6N4E). The H-PGDS is presented in surface (coloured in purple); quinoline-3-carboxamide is shown in spheres (coloured in yellow). (B) The complex structure of H - PGDS -quinoline-3-carboxamide . The H-PGDS is presented in ribbon (coloured in purple); quinoline-3-carboxamide is shown in spheres (coloured in yellow). (C) Generated pharmacophore features and structure of the H - PGDS -quinoline-3-carboxamide . (The interactive residues of H - PGDS are shown as sticks (gray) and labelled. The quinoline-3-carboxamide is presented in balls-and-sticks (pink). (D) Features at a specific distance correspond to the pharmacophore model Phar-A2HR2 . Pharmacophore features are color‐coded as follows: hydrogen-bond acceptor, green; hydrophobic feature, cyan; ring aromatic feature, orange.
Hypogen Pxr Pharmacophores, supplied by Hypogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/automated+pharmacophore+model+module/hypogen+pxr+pharmacophores/pm18384689-256-1-0
Average 90 stars, based on 1 article reviews
hypogen pxr pharmacophores - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
pharmacophoric models  (Melet Schloesing)
90
Melet Schloesing pharmacophoric models
<t>Receptor-ligand-pharmacophore</t> generation based on the complex structure of the H-PGDS-quinoline-3-carboxamide. (A) The complex structure of H - PGDS -quinoline-3-carboxamide (PDB ID: 6N4E). The H-PGDS is presented in surface (coloured in purple); quinoline-3-carboxamide is shown in spheres (coloured in yellow). (B) The complex structure of H - PGDS -quinoline-3-carboxamide . The H-PGDS is presented in ribbon (coloured in purple); quinoline-3-carboxamide is shown in spheres (coloured in yellow). (C) Generated pharmacophore features and structure of the H - PGDS -quinoline-3-carboxamide . (The interactive residues of H - PGDS are shown as sticks (gray) and labelled. The quinoline-3-carboxamide is presented in balls-and-sticks (pink). (D) Features at a specific distance correspond to the pharmacophore model Phar-A2HR2 . Pharmacophore features are color‐coded as follows: hydrogen-bond acceptor, green; hydrophobic feature, cyan; ring aromatic feature, orange.
Pharmacophoric Models, supplied by Melet Schloesing, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/automated+pharmacophore+model+module/pharmacophoric+models/pmc02998687-301-0-26
Average 90 stars, based on 1 article reviews
pharmacophoric models - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
central region of α-msh that serves as the pharmacophore for melanocortin receptors (ehfrw)  (GenScript corporation)
90
GenScript corporation central region of α-msh that serves as the pharmacophore for melanocortin receptors (ehfrw)
<t>Receptor-ligand-pharmacophore</t> generation based on the complex structure of the H-PGDS-quinoline-3-carboxamide. (A) The complex structure of H - PGDS -quinoline-3-carboxamide (PDB ID: 6N4E). The H-PGDS is presented in surface (coloured in purple); quinoline-3-carboxamide is shown in spheres (coloured in yellow). (B) The complex structure of H - PGDS -quinoline-3-carboxamide . The H-PGDS is presented in ribbon (coloured in purple); quinoline-3-carboxamide is shown in spheres (coloured in yellow). (C) Generated pharmacophore features and structure of the H - PGDS -quinoline-3-carboxamide . (The interactive residues of H - PGDS are shown as sticks (gray) and labelled. The quinoline-3-carboxamide is presented in balls-and-sticks (pink). (D) Features at a specific distance correspond to the pharmacophore model Phar-A2HR2 . Pharmacophore features are color‐coded as follows: hydrogen-bond acceptor, green; hydrophobic feature, cyan; ring aromatic feature, orange.
Central Region Of α Msh That Serves As The Pharmacophore For Melanocortin Receptors (Ehfrw), supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/automated+pharmacophore+model+module/central+region+of+%CE%B1+msh+that+serves+as+the+pharmacophore+for+melanocortin+receptors++ehfrw+/10__3390_slash_molecules16097331-86-27-36
Average 90 stars, based on 1 article reviews
central region of α-msh that serves as the pharmacophore for melanocortin receptors (ehfrw) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
pharmacophores and pharmacophore searches  (Verlag GmbH)
90
Verlag GmbH pharmacophores and pharmacophore searches
<t>Receptor-ligand-pharmacophore</t> generation based on the complex structure of the H-PGDS-quinoline-3-carboxamide. (A) The complex structure of H - PGDS -quinoline-3-carboxamide (PDB ID: 6N4E). The H-PGDS is presented in surface (coloured in purple); quinoline-3-carboxamide is shown in spheres (coloured in yellow). (B) The complex structure of H - PGDS -quinoline-3-carboxamide . The H-PGDS is presented in ribbon (coloured in purple); quinoline-3-carboxamide is shown in spheres (coloured in yellow). (C) Generated pharmacophore features and structure of the H - PGDS -quinoline-3-carboxamide . (The interactive residues of H - PGDS are shown as sticks (gray) and labelled. The quinoline-3-carboxamide is presented in balls-and-sticks (pink). (D) Features at a specific distance correspond to the pharmacophore model Phar-A2HR2 . Pharmacophore features are color‐coded as follows: hydrogen-bond acceptor, green; hydrophobic feature, cyan; ring aromatic feature, orange.
Pharmacophores And Pharmacophore Searches, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/automated+pharmacophore+model+module/pharmacophore+model/10__1016_slash_j__ejmech__2017__08__017-799-12-17
Average 90 stars, based on 1 article reviews
pharmacophores and pharmacophore searches - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
pharmacophore-based virtual screening database  (MolPort Inc)
90
MolPort Inc pharmacophore-based virtual screening database
<t>Receptor-ligand-pharmacophore</t> generation based on the complex structure of the H-PGDS-quinoline-3-carboxamide. (A) The complex structure of H - PGDS -quinoline-3-carboxamide (PDB ID: 6N4E). The H-PGDS is presented in surface (coloured in purple); quinoline-3-carboxamide is shown in spheres (coloured in yellow). (B) The complex structure of H - PGDS -quinoline-3-carboxamide . The H-PGDS is presented in ribbon (coloured in purple); quinoline-3-carboxamide is shown in spheres (coloured in yellow). (C) Generated pharmacophore features and structure of the H - PGDS -quinoline-3-carboxamide . (The interactive residues of H - PGDS are shown as sticks (gray) and labelled. The quinoline-3-carboxamide is presented in balls-and-sticks (pink). (D) Features at a specific distance correspond to the pharmacophore model Phar-A2HR2 . Pharmacophore features are color‐coded as follows: hydrogen-bond acceptor, green; hydrophobic feature, cyan; ring aromatic feature, orange.
Pharmacophore Based Virtual Screening Database, supplied by MolPort Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/automated+pharmacophore+model+module/pharmacophore+query/pmc09201829-244-4-14
Average 90 stars, based on 1 article reviews
pharmacophore-based virtual screening database - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
molport-003-703-800  (MolPort Inc)
90
MolPort Inc molport-003-703-800
<t>Receptor-ligand-pharmacophore</t> generation based on the complex structure of the H-PGDS-quinoline-3-carboxamide. (A) The complex structure of H - PGDS -quinoline-3-carboxamide (PDB ID: 6N4E). The H-PGDS is presented in surface (coloured in purple); quinoline-3-carboxamide is shown in spheres (coloured in yellow). (B) The complex structure of H - PGDS -quinoline-3-carboxamide . The H-PGDS is presented in ribbon (coloured in purple); quinoline-3-carboxamide is shown in spheres (coloured in yellow). (C) Generated pharmacophore features and structure of the H - PGDS -quinoline-3-carboxamide . (The interactive residues of H - PGDS are shown as sticks (gray) and labelled. The quinoline-3-carboxamide is presented in balls-and-sticks (pink). (D) Features at a specific distance correspond to the pharmacophore model Phar-A2HR2 . Pharmacophore features are color‐coded as follows: hydrogen-bond acceptor, green; hydrophobic feature, cyan; ring aromatic feature, orange.
Molport 003 703 800, supplied by MolPort Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/automated+pharmacophore+model+module/molport+003+703+800/pmc09668091-231-8-13
Average 90 stars, based on 1 article reviews
molport-003-703-800 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Receptor-ligand-pharmacophore generation based on the complex structure of the H-PGDS-quinoline-3-carboxamide. (A) The complex structure of H - PGDS -quinoline-3-carboxamide (PDB ID: 6N4E). The H-PGDS is presented in surface (coloured in purple); quinoline-3-carboxamide is shown in spheres (coloured in yellow). (B) The complex structure of H - PGDS -quinoline-3-carboxamide . The H-PGDS is presented in ribbon (coloured in purple); quinoline-3-carboxamide is shown in spheres (coloured in yellow). (C) Generated pharmacophore features and structure of the H - PGDS -quinoline-3-carboxamide . (The interactive residues of H - PGDS are shown as sticks (gray) and labelled. The quinoline-3-carboxamide is presented in balls-and-sticks (pink). (D) Features at a specific distance correspond to the pharmacophore model Phar-A2HR2 . Pharmacophore features are color‐coded as follows: hydrogen-bond acceptor, green; hydrophobic feature, cyan; ring aromatic feature, orange.

Journal: Journal of Enzyme Inhibition and Medicinal Chemistry

Article Title: Discovery and characterization of novel hematopoietic prostaglandin D synthase inhibitors from traditional Chinese medicine: the bioactive potential of dihydroberberine in treatments of Duchenne muscular dystrophy and inflammation-related diseases

doi: 10.1080/14756366.2025.2555624

Figure Lengend Snippet: Receptor-ligand-pharmacophore generation based on the complex structure of the H-PGDS-quinoline-3-carboxamide. (A) The complex structure of H - PGDS -quinoline-3-carboxamide (PDB ID: 6N4E). The H-PGDS is presented in surface (coloured in purple); quinoline-3-carboxamide is shown in spheres (coloured in yellow). (B) The complex structure of H - PGDS -quinoline-3-carboxamide . The H-PGDS is presented in ribbon (coloured in purple); quinoline-3-carboxamide is shown in spheres (coloured in yellow). (C) Generated pharmacophore features and structure of the H - PGDS -quinoline-3-carboxamide . (The interactive residues of H - PGDS are shown as sticks (gray) and labelled. The quinoline-3-carboxamide is presented in balls-and-sticks (pink). (D) Features at a specific distance correspond to the pharmacophore model Phar-A2HR2 . Pharmacophore features are color‐coded as follows: hydrogen-bond acceptor, green; hydrophobic feature, cyan; ring aromatic feature, orange.

Article Snippet: The modelling process was conducted with the receptor-ligand pharmacophore generation module in Discovery Studio 2021 (Accelrys Software, Inc., San Diego, CA, USA).

Techniques: Generated

Chemical structures of the identified top10 ranked hits from pharmacophore-based inhibitor screening.

Journal: Journal of Enzyme Inhibition and Medicinal Chemistry

Article Title: Discovery and characterization of novel hematopoietic prostaglandin D synthase inhibitors from traditional Chinese medicine: the bioactive potential of dihydroberberine in treatments of Duchenne muscular dystrophy and inflammation-related diseases

doi: 10.1080/14756366.2025.2555624

Figure Lengend Snippet: Chemical structures of the identified top10 ranked hits from pharmacophore-based inhibitor screening.

Article Snippet: The modelling process was conducted with the receptor-ligand pharmacophore generation module in Discovery Studio 2021 (Accelrys Software, Inc., San Diego, CA, USA).

Techniques: